Markets likely to open flat following mixed global cues

Benchmark indices are expected to open flat with a negative bias following muted global trends and no immediate positive triggers for the markets. The early indicator, SGX Nifty is trading 0.2% lower.

On Tuesday, the Sensex gained 104.37 points to end at 25,864.47 and the Nifty rose 30.95 points at 7,837.55. The Nifty is expected to trade in range today.

The US economic data released yesterday showed some positivity in consumer prices as well as manufacturing data thus providing room for a December rate hike case.

GLOBAL MARKETS

Asian markets are trading mixed with Nikkei up by 0.8% while Shanghai Composite and Hang Seng down between 0.1-0.3%

The Wall Street ended flat after opening higher. But the economic data released yesterday supported the Fed’s case for a December rate hike.

The American dollar rose against major currencies in the currency basket on Tuesday.

STOCK TRENDS

Aviation Stocks: The Competition Commission of India (CCI), fair trade regulator on Tuesday found Jet Airways, IndiGo and SpiceJet guilty of colluding in fixing fuel surcharge rates for transporting cargo. The CCI in its final order passed on Tuesday imposed a fine totalling Rs 257.91 crore on the three carriers.

Tata Steel: Tata Steel’s Kalinganagar project is some way off from rolling out steel as Odisha Chief Minister Naveen Patnaik is set to dedicate the plant to the state today.

Infosys: Infosys said it is looking to step up hiring in the US, especially fresh graduates from the campuses of top American educational institutions, even though the company reiterated that a significant talent gap still exists in the country.

GSK Pharma: GlaxoSmithKline Pharmaceuticals (GSK Pharma) has stepped up its focus on its vaccine business with a price cut in its top-selling pneumonia vaccine. It has also lined up two product launches for next year.

Pfizer: Drugmaker Pfizer's plans to take over Allergan have faced a political backlash in the United States over fears a deal would lead to the company shifting its headquarters and taxable profits to Ireland.

Piramal Healthcare: Piramal Healthcare has invested two million pounds (about Rs 20 crore) to expand its manufacturing plant in Scotland. The plant manufactures anti-cancer drugs (antibody drug conjugates) for export.

Metal stocks: The global commodity prices crashed overnight following which the metal stocks such as Hindalco, Vedanta, JSW Steel will be in focus


Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel